FamilyNet smart speaker/mobile application for Defiant Disorder, Oppositional

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Oregon Research Behavioral Intervention Strategies, Inc., Eugene, OR
Defiant Disorder, Oppositional+3 More
FamilyNet smart speaker/mobile application - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This project will develop and evaluate the feasibility of an integrated smart speaker and mobile/web-based application, "FamilyNet" (FN) to assist parents in implementing empirically supported behavioral parenting strategies to promote positive behavior change in their children. The FamilyNet system will help parents to create a positively framed, individualized behavioral plan for their child(ren), and then provide prompts, reminders, and tracking tools to help them effectively implement that plan. Once developed, FamilyNet will be field tested for usability and usefulness with a group of parents who have children ages 12-15 years exhibiting challenging behaviors. Establishing feasibility of this innovative parenting tool will have important implications for harnessing smart speaker and mobile/web technologies to provide parents in-situ support with parenting challenges; parents' effective implementation of empirically supported parenting strategies is likely to increase children's prosocial behaviors and reduce problematic behaviors, thus reducing their risk for long-term behavioral problems.

Eligible Conditions

  • Defiant Disorder, Oppositional
  • Conduct Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Defiant Disorder, Oppositional

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: Post-treatment (T2 -Months 13-17)

Month 12
Families' usage of FamilyNet
Parent Daily Report of Child Behavior
Post-treatment (T2 -Months 13-17)
Adult-Adolescent Parenting Inventory 2
Intervention Attitude Inventory
Strengths and Difficulties Questionnaire
System Usability Scale

Trial Safety

Safety Progress

1 of 3

Other trials for Defiant Disorder, Oppositional

Trial Design

1 Treatment Group

FamilyNet smart speaker/mobile application
1 of 1
Experimental Treatment

35 Total Participants · 1 Treatment Group

Primary Treatment: FamilyNet smart speaker/mobile application · No Placebo Group · N/A

FamilyNet smart speaker/mobile application
Behavioral
Experimental Group · 1 Intervention: FamilyNet smart speaker/mobile application · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post-treatment (t2 -months 13-17)
Closest Location: Oregon Research Behavioral Intervention Strategies, Inc. · Eugene, OR
Photo of oregon 1Photo of oregon 2Photo of oregon 3
2021First Recorded Clinical Trial
1 TrialsResearching Defiant Disorder, Oppositional
7 CompletedClinical Trials

Who is running the clinical trial?

Oregon Research Behavioral Intervention Strategies, Inc.Lead Sponsor
17 Previous Clinical Trials
13,430 Total Patients Enrolled
David R. Smith, PhDPrincipal InvestigatorOregon Research Behavioral Intervention Strategies, Inc.
1 Previous Clinical Trials
44 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a child who is 12 to 15 years old and lives with you at least half the time.
You must speak English.
The target child has a S&D score of 14 or greater.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.